Home Markets Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210

You May Also Like

Japan’s record bull run under threat as Mideast war clouds earnings season

Australia’s Atlas Arteria receives up to $4.9 bln takeover bid from IFM Investors

India’s Sun Pharma to acquire US-listed Organon in $11.8 billion deal

Trump disclosures show $51M+ invested in bonds in March

Buy these memory stocks to play the red-hot CPU trade: Analyst

Brands and Retailers: What is the state of the marketing landscape